81 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34827096 | Chemo-Sensitization of CD133+ Cancer Stem Cell Enhances the Effect of Mesenchymal Stem Cell Expressing TRAIL in Non-Small Cell Lung Cancer Cell Lines. | 2021 Oct 26 | 4 |
2 | 32020226 | Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapy. | 2020 Apr | 1 |
3 | 32368398 | Cisplatin sensitivity mediated by NKX2-1 in lung adenocarcinoma is dependent on p53 mutational status via modulating TNFSF10 expression. | 2020 | 3 |
4 | 30724400 | Inhibition of N-myc expression sensitizes human neuroblastoma IMR-32 cells expressing caspase-8 to TRAIL. | 2019 May | 2 |
5 | 30805008 | Human Embryonic Stem Cells Acquire Responsiveness to TRAIL upon Exposure to Cisplatin. | 2019 | 2 |
6 | 31498788 | Designing combination therapies with modeling chaperoned machine learning. | 2019 Sep | 1 |
7 | 29849953 | Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer. | 2018 May 11 | 2 |
8 | 28202521 | Ex Vivo Explant Cultures of Non-Small Cell Lung Carcinoma Enable Evaluation of Primary Tumor Responses to Anticancer Therapy. | 2017 Apr 15 | 1 |
9 | 28671676 | JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells. | 2017 Jul 3 | 3 |
10 | 29182622 | Cisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10. | 2017 | 2 |
11 | 29297126 | The effect of cisplatin on cytotoxicity of anticancer cytokine TRAIL and its receptor-selective mutant variant DR5-B1. | 2017 Nov | 3 |
12 | 26542757 | Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/trail-Cisplatin combination therapy in cervical cancer. | 2016 Feb | 2 |
13 | 26794656 | Flavonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV⁺ cells. | 2016 Jan 21 | 1 |
14 | 27035109 | Mild oxidative stress induced by a low dose of cisplatin contributes to the escape of TRAIL-mediated apoptosis in the ovarian cancer SKOV3 cell line. | 2016 Jun | 6 |
15 | 25186100 | Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors. | 2015 Jan | 2 |
16 | 25695324 | Inhibition of livin expression suppresses cell proliferation and enhances chemosensitivity to cisplatin in human lung adenocarcinoma cells. | 2015 Jul | 1 |
17 | 25796504 | Cisplatin-mediated c-myc overexpression and cytochrome c (cyt c) release result in the up-regulation of the death receptors DR4 and DR5 and the activation of caspase 3 and caspase 9, likely responsible for the TRAIL-sensitizing effect of cisplatin. | 2015 Apr | 5 |
18 | 26463141 | [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells]. | 2015 Jun | 3 |
19 | 26492363 | Activation of surrogate death receptor signaling triggers peroxynitrite-dependent execution of cisplatin-resistant cancer cells. | 2015 Oct 22 | 4 |
20 | 24345465 | Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment. | 2014 Mar | 2 |
21 | 25285768 | Platinum(IV) complex LA-12 exerts higher ability than cisplatin to enhance TRAIL-induced cancer cell apoptosis via stimulation of mitochondrial pathway. | 2014 Dec 1 | 2 |
22 | 23258590 | Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells. | 2013 Feb | 1 |
23 | 23826494 | Synergistic Effect of Subtoxic-dose Cisplatin and TRAIL to Mediate Apoptosis by Down-regulating Decoy Receptor 2 and Up-regulating Caspase-8, Caspase-9 and Bax Expression on NCI-H460 and A549 Cells. | 2013 May | 4 |
24 | 23846221 | Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing. | 2013 Jul 11 | 2 |
25 | 23912708 | Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells. | 2013 Oct | 1 |
26 | 20856198 | Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis. | 2011 Feb 3 | 1 |
27 | 20876774 | Identification of c-FLIP(L) and c-FLIP(S) as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells. | 2011 Feb | 3 |
28 | 21037225 | Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway. | 2011 Jan | 5 |
29 | 21152876 | Cisplatin sensitizes human hepatocellular carcinoma cells, but not hepatocytes and mesenchymal stem cells, to TRAIL within a therapeutic window partially depending on the upregulation of DR5. | 2011 Feb | 3 |
30 | 21252285 | Enhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cells. | 2011 Mar | 1 |
31 | 21291526 | Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma. | 2011 Feb 3 | 5 |
32 | 21487429 | Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis. | 2011 Apr 12 | 1 |
33 | 21877938 | Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP. | 2011 Oct | 2 |
34 | 22093622 | [Cisplatin enhances TRAIL-induced apoptosis in gastric cancer cells through clustering death receptor 4 into lipid rafts]. | 2011 Jul | 5 |
35 | 20157422 | The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer. | 2010 Jan 18 | 2 |
36 | 20213096 | The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma. | 2010 Dec | 4 |
37 | 20623264 | Cisplatin-enhanced sensitivity of glioblastoma multiforme U251 cells to adenovirus-delivered TRAIL in vitro. | 2010 Dec | 3 |
38 | 19590723 | TRAIL-induced cell death and caspase-8 activation are inhibited by cisplatin but not carboplatin. | 2009 Jun | 5 |
39 | 19625063 | Oxidative stress sensitizes bladder cancer cells to TRAIL mediated apoptosis by down-regulating anti-apoptotic proteins. | 2009 Sep | 1 |
40 | 19661294 | Cytotoxic effects of camptothecin and cisplatin combined with tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) in a model of primary culture of non-small cell lung cancer. | 2009 Aug | 2 |
41 | 19834905 | Identification of molecular targets for selective elimination of TRAIL-resistant leukemia cells. From spots to in vitro assays using TOP15 charts. | 2009 Nov | 1 |
42 | 19852930 | Association of caspase-8 mutation with chemoresistance to cisplatin in HOC313 head and neck squamous cell carcinoma cells. | 2009 Dec 18 | 1 |
43 | 19957654 | [Synergistic effects and mechanisms of combined tumor necrosis factor-related apoptosis-inducing ligand and chemotherapeutic drugs or radiotherapy in killing laryngeal squamous carcinoma cells in vitro]. | 2009 Jul | 3 |
44 | 18191995 | Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells. | 2008 Mar | 7 |
45 | 18309355 | Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway. | 2008 Jun | 5 |
46 | 17376311 | Induction of apoptosis in osteogenic sarcoma cells by combination of tumor necrosis factor-related apoptosis inducing ligand and chemotherapeutic agents. | 2007 Mar 5 | 2 |
47 | 17379655 | Tumor necrosis factor-related apoptosis inducing ligand expression and activity in hen granulosa cells. | 2007 Mar | 2 |
48 | 17441316 | Combination of gamma-interferon with TRAIL and cisplatin or etoposide induces apoptosis in human neuroblastoma cell line SH-SY5Y. | 2007 Mar | 2 |
49 | 17577631 | Synergistic induction of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying TRAIL. | 2007 Oct | 3 |
50 | 17693058 | Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells. | 2007 Nov | 1 |